KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Net Income towards Common Stockholders (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Net Income towards Common Stockholders for 10 consecutive years, with -$23.4 million as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders fell 297.72% to -$23.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$60.5 million through Dec 2025, down 41.69% year-over-year, with the annual reading at -$60.5 million for FY2025, 41.69% down from the prior year.
  • Net Income towards Common Stockholders hit -$23.4 million in Q4 2025 for Fulgent Genetics, down from -$6.6 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $200.7 million in Q1 2021 to a low of -$128.1 million in Q4 2023.
  • Historically, Net Income towards Common Stockholders has averaged $18.7 million across 5 years, with a median of -$10.0 million in 2023.
  • Biggest five-year swings in Net Income towards Common Stockholders: surged 11856.94% in 2021 and later plummeted 1075.95% in 2023.
  • Year by year, Net Income towards Common Stockholders stood at $103.7 million in 2021, then plummeted by 123.22% to -$24.1 million in 2022, then plummeted by 432.27% to -$128.1 million in 2023, then skyrocketed by 95.41% to -$5.9 million in 2024, then tumbled by 297.72% to -$23.4 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for FLGT at -$23.4 million in Q4 2025, -$6.6 million in Q3 2025, and -$19.0 million in Q2 2025.